SummarY
Introduction p-Chlorophenoxyisobutyrate is the active metabolite of clofibrate, which is used in the management of hypertriglyceridaemia. In addition to lowering plasma very-low-density lipoprotein concentrations, CPIB") decreases plasma non-esterified fatty acids (Barrett & Thorp, 1968) . These effects are possibly related since there is evidence that NEFA may influence hepatic very-low-density lipoprotein synthesis (Nestel & Steinberg, 1963) .
The mechanism whereby CPIB lowers plasma NEFA concentrations is uncertain. Barrett (1966) showed that CPIB inhibits the release of NEFA from adipose tissue in uitro, suggesting that it might reduce NEFA influx into plasma. Spector &Soboroff (1971), on the other hand, found that CPIB also increases the uptake of NEFA by cultured ascites tumour cells and proposed that it enhances the removal of NEFA from plasma by competing for albumin-binding sites. NEFA turnover studies in uivo have failed to identify the relative importance of these processes (Barter, Nestel & Carroll, 1972; Wolfe, Kane, Have1 & Brewster, 1973) .
We have attempted to clarify the mode of action of CPIB by relating the reduction in plasma NEFA concentration in dogs to the associated changes in NEFA and glycerol release from subcutaneous adipose tissue in situ.
Methods

Experimental procedures
Seven female dogs (15-18 kg), kept without food overnight, were studied. Anaesthesia was induced with pentobarbitone [0.11 mmol (25 mg)/kg], and N. E. Miller, 0. D. Mjos and M . F. Oliver ventilation maintained with a positive-pressure respirator. A femoral vein was cannulated for infusions, and a femoral artery for blood withdrawal and monitoring of blood pressure and heart rate. After intravenous injection of heparin (5 mg/kg), the left inguinal fat pad was isolated from all surrounding tissues (Rosell, 1966) . The adipose tissue vein was cannulated and allowed to drain into a chilled (4°C) measuring cylinder, the main artery and nerve being left intact. Three collections of the venous effluent, each of 15 min duration, were made: a control collection, a second collection, commenced 10 min after the start of a continuous intravenous infusion of isoprenaline [ 1.2 nmol(O.25 p g ) min-' kg-'1 and a third collection, during an identical isoprenaline infusion, commenced 45 min after intravenous administration of sodium CPIB [93 pmol (20 mg)/kg]. The time-interval between the heparin infusion and the start of the first collection was 80-100 min. Between the second and third collections, isoprenaline was not infused and the venous effluent was returned via the cannulated femoral vein. Arterial blood was sampled on three occasions during each collection and, in four animals, also before heparin infusion. After each experiment the adipose tissue was excised and weighed (mean weight 10.1 g).
Laboratory procedures
Plasma NEFA were assayed according to Trout, Estes & Friedberg (1960) , plasma CPIB as described by Barrett & Thorp (1968) and blood free glycerol by an enzymatic method (Chernick, 1969) . Plasma NEFA were corrected for the presence of CPIB (Barrett & Thorp, 1968) . Blood packed cell volume was measured by standard technique.
Calculations
Since the NEFA of blood are contained almost entirely in the plasma (Ways & Hanahan, 1964) , the rate of NEFA release from adipose tissue was calculated as the product of the arteriovenous difference in plasma NEFA concentration and the plasma flow per gram of adipose tissue. Glycerol release was calculated from the arteriovenous difference in blood free glycerol concentration and blood flow. Statistical analyses were performed by standard parametric procedures (Snedecor, 1956 ).
Results
The experimental observations appear in Table 1 . Isoprenaline infusion stimulated NEFA and glycerol release from adipose tissue and increased their arterial concentrations. In the pooled data before CPIB administration, arterial NEFA concentration (mmol/l) was linearly related to NEFA release (nmol min-' g-'): r = +0.90, P<O.001; NEFA concentra- 
Discussion
It is well established that the concentration and turnover of plasma NEFA under normal circumstances are determined mainly by their total rate of influx into plasma from adipose tissue (Nikkila, 1971) . In the present experiments, the rate of NEFA release from subcutaneous adipose tissue correlated strongly with the arterial NEFA concentration in results obtained under basal conditions and during infusion of isoprenaline. This indicates that the preparations employed were representative of adipose tissue elsewhere, and provided a reliable system for monitoring NEFA mobilization in vivo. Administration of sodium CPIB produced plasma CPIB concentrations similar to those observed during clofibrate therapy in man (Wolfe et at., 1973) and was followed in each experiment by a substantial reduction in the arterial NEFA concentration during isoprenaline infusion. Since the increment in arterial NEFA concentration induced by isoprenaline under the present experimental conditions has been shown to be reproducible (Mjas, Miller, Riemersma & Oliver, 1976) , its reduction cannot be attributed to tachyphylaxis. Nor is it likely to have been related to the use of heparin (Robinson, 1963) , since in four animals the arterial NEFA concentration during the first venous collection was similar to that before heparinization.
The decrease in arterial NEFA concentration after CPIB was accompanied by a significant reduction in the release of NEFA from adipose tissue. In the pooled data, the decrement in NEFA concentration was proportional to that in NEFA release, the normal linear regression between these two measurements being unchanged. These findings suggest that the decrease of arterial NEFA concentration by CPIB reflected a decrease in the mobilization of NEFA from adipose tissue, with no alteration in plasma NEFA clearance. This conclusion is supported by the previously demonstrated failure of CPIB to increase the fractional extraction of NEFA by the canine myocardium (Mjss et a!., 1976) .
The release of glycerol from adipose tissue was also inhibited by CPIB, but to a significantly lesser extent than that of NEFA. Since the only important source of glycerol in adipose tissue is the hydrolysis of glyceride (Lynn, MacLeod & Brown, 1960) , and since adipose tissue is unable to re-utilize or oxidize glycerol in signscant amounts (Shapiro, Chowers & Rose, 1957) , its rate of release may be used as a measure of lipolysis (Steinberg & Vaughan, 1965) . The re-esterification of NEFA in adipose tissue is reflected in the ratio of NEFA release to glycerol release (Steinberg & Vaughan, 1965) . The present data thus indicate that the reduction of NEFA mobilization by CPIB was due partly to inhibited lipolysis and partly to enhanced NEFA re-esterikation. An inhibition of adipose tissue lipolysis by CPIB under conditions in vitro has been well documented, when it appears to result from diminished adenyl cyclase activity (D'Costa & Angel, 1975) . However, the possibility that CPIB might also influence NEFA reesterilkation has not been investigated. Further studies are required to determine whether this is a direct or indirect effect of CPIB.
